Global Automated Nucleic Acid Isolation Platform Market Strategic Research Report

Scope of the Report

The global Automated Nucleic Acid Isolation Platform market size is predicted to grow from US$ 669 million in 2025 to US$ 930 million in 2032; it is expected to grow at a CAGR of 4.9% from 2026 to 2032.

The automated nucleic acid isolation platform is a device used to extract nucleic acids (such as DNA, RNA) from biological samples efficiently, accurately and reproducibly. These platforms are commonly used in areas such as molecular biology research, clinical diagnostics, and biological sample processing.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report presents a comprehensive overview of the global Automated Nucleic Acid Isolation Platform market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• DNA Isolation
• RNA Isolation

Segment by Application

• Outpatient Lab
• Hospital
• Testing Agency
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Automated Nucleic Acid Isolation Platform market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Outpatient Lab, Hospital, Testing Agency evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact